Sign in
Companies / SOLV vs BAX

SOLV vs BAX: Solventum and Baxter International

Medical Devices
Compare more companies

Solventum (SOLV) reported $8.3B in revenue against a 18.7% net margin, while Baxter International (BAX) reported $11.2B at a -8.5% net margin, most recently.

MetricSOLVBAX
Revenue$8.3B$11.2B
Net Income$1.6B$-1.0B
Gross Margin53.5%30.1%
Operating Margin26.2%-2.7%
EPS (Diluted)$8.88$-1.87
Free Cash Flow$-10.0M$0.3B
Total Debt$5.0B$9.5B
P/E Ratio8.9×n/m
P/B Ratio2.7×n/m
Stock Price$87.11$25.64
Fiscal yearFY2022FY2023FY2024FY2025
SOLV Revenue$8.1B$8.2B$8.3B$8.3B
BAX Revenue$10.1B$10.4B$10.6B$11.2B

More on SOLV

More on BAX

Other comparisons